GAGNON ROBERT E. (Chief Financial Officer) sold 1.3% of their position (7.78K shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $22.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/27/2026ACC: 0000905148-26-003351
Officer· Chief Financial Officer
Since Sep 2025
-7.78K
Net shares
Net seller
$22.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.78K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.78K
Price / share
$2.95
Trade value
$22.94K
% of position
1.3%
7/23/2026
592.16K→584.38K
Total
Net shares
−7.78K
Net value
-$22.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/23/2026 | S · Sale | −7.78K | $2.95 | $22.94K | 1.3% | 592.16K | 584.38K |
| Total | −7.78K | -$22.94K | ||||||
Derivative Transactions0
No derivative transactions reported